12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Monday's intraday session. Harpoon Therapeutics (HARP) saw a 112.4% increase, while LumiraDx (LMDX) dropped by 45.6%. Other notable gainers include Ambrx Biopharma (AMAM), Nkarta (NKTX), Universe Pharmaceuticals (UPC), Elevation Oncology (ELEV), and Venus Concept (VERO). On the losing side, Revance Therapeutics (RVNC), Prothena Corp (PRTA), Inspire Veterinary (IVP), Pacific Biosciences (PACB), and Jin Medical International (ZJYL) saw declines.
January 08, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
LumiraDx stock plummeted by 45.6%, with a market cap of $5.9 million.
The significant drop in LumiraDx's stock price could reflect negative investor sentiment or disappointing company news, likely leading to further short-term bearish behavior.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Ambrx Biopharma's stock rose by 100.07%, reaching a market cap of $1.7 billion.
The doubling of Ambrx Biopharma's stock price suggests a very positive development for the company, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Elevation Oncology's stock rose by 36.06%, with a market cap of $50.4 million.
Elevation Oncology's stock increase may continue in the short term if the market perceives the company's prospects positively.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Harpoon Therapeutics stock surged 112.4% with a market cap of $379.3 million.
The substantial increase in stock price for Harpoon Therapeutics indicates strong investor confidence and positive market sentiment, which could lead to continued short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Nkarta shares increased by 52.14%, with a market cap of $452.4 million.
Nkarta's significant stock price increase could be driven by positive news or investor sentiment, which may result in continued short-term appreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Universe Pharmaceuticals stock jumped 38.31%, with a market cap of $8.3 million.
The notable increase in Universe Pharmaceuticals' stock price could attract more investor interest, potentially leading to further short-term gains.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Venus Concept stock increased by 35.65%, with a market cap of $8.6 million.
Venus Concept's stock price gain suggests positive investor sentiment, which might lead to further short-term increases.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100